Literature DB >> 2949334

Psychologic predictors of psychosocial and medical outcomes in patients undergoing coronary angioplasty.

R E Shaw, F Cohen, J Fishman-Rosen, M C Murphy, S H Stertzer, D A Clark, R K Myler.   

Abstract

The relationship between psychologic variables (the match between repressive style and level of cardiac information, and anxiety level) and medical complications, re-stenosis (renarrowing), and psychosocial adjustment was studied in 97 patients undergoing percutaneous transluminal coronary angioplasty (PTCA) for treatment of narrowed coronary arteries. Three major findings emerged for outcomes measured 6 months after PTCA: repressors with a high level of cardiac information (coping style-information level mismatch) and no history of heart attack were at higher risk for late medical complications (p less than 0.001); sensitizers with a low level of cardiac information (coping style-information level mismatch) and whose PTCA was only moderately successful were at higher risk for re-stenosis of the artery previously widened during PTCA (p less than 0.01); and patients who were more anxious during hospitalization had poorer social functioning and more mood disturbance 6 months after PTCA (p less than 0.05). Thus, psychologic, information, and medical factors are important in predicting 6-month outcomes in patients undergoing PTCA.

Entities:  

Mesh:

Year:  1986        PMID: 2949334     DOI: 10.1097/00006842-198611000-00005

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  2 in total

1.  How goal disturbance, coping and chest pain relate to quality of life: A study among patients waiting for PTCA.

Authors:  M A Echteld; T M van Elderen; L J van der Kamp
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Psychological status and the role of coping style after coronary artery bypass graft surgery. Results of a prospective study.

Authors:  H Boudrez; G De Backer
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.